EPOPROSTENOL 0,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

epoprostenol 0,5 mg

mercury pharmaceuticals ltd - marea britanie - epoprostenolum - pulb. + solv. pt. sol. perf. - 0,5mg - antitrombotice antiagregante plachetare

TRESUVI 1 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tresuvi 1 mg/ml

aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 1mg/ml - antitrombotice antiagregante plachetare

TRESUVI 10 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tresuvi 10 mg/ml

aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 10mg/ml - antitrombotice antiagregante plachetare

TRESUVI 2,5 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tresuvi 2,5 mg/ml

aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 2,5mg/ml - antitrombotice antiagregante plachetare

TRESUVI 5 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tresuvi 5 mg/ml

aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 5mg/ml - antitrombotice antiagregante plachetare

Digoxin comprimate 0,25 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

digoxin comprimate 0,25 mg

centrul stiintific de producere "uzina chimico-farmaceutica borsceagov" sai - digoxinum - comprimate - 0,25 mg

Volibris Uniunea Europeană - română - EMA (European Medicines Agency)

volibris

glaxosmithkline (ireland) limited - ambrisentan - hipertensiune arterială, pulmonară - antihipertensive, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

PENTOXIFILINA SR ZENTIVA 400 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pentoxifilina sr zentiva 400 mg

saneca pharmaceuticals a.s. - republica slovaca - pentoxifyllinum - compr. cu elib. prel. - 400mg - vasodilatatoare periferice derivati purinici